There is increasing concern from various professions, as well as in the sciences, about the influence of corporate funding on activities, as well as directions taken. In 2002, the American Psychological Association President at the time, Phil Zimbardo attended a meeting held by the American Psychiatric Association (American Psychological Association (APA)). The nature of the exhibits, which were under the sponsorship of the pharmaceutical companies, surprised him. Due to the prescription privileges enjoyed by psychologists, there was fear that pharmaceutical companies would gain stronger interest in providing sponsorship for events organized by APA (Angell, 2004). Hence, this gave rise Continue reading...